Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Liquidia Corporation (LQDA) Stock Analysis: A 118.59% Potential Upside Opportunity in Biotech 17 June 2025
Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 218% Potential Upside in the Biotech Sector 17 June 2025
10x Genomics, Inc. (TXG) Stock Report: Exploring Potential Upside Amid Healthcare Sector Dynamics 17 June 2025
Artivion, Inc. (AORT) Stock Analysis: A 12.54% Upside Potential Amidst Healthcare Innovations 17 June 2025
GRAIL, Inc. (GRAL) Stock Analysis: Navigating Challenges with a 19% Revenue Growth in Healthcare Innovation 17 June 2025
Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with 11.9% Revenue Surge and Strategic Buy Ratings 17 June 2025
Vera Therapeutics, Inc. (VERA) Stock Analysis: Biotech Innovator with 189.96% Upside Potential 17 June 2025
AdaptHealth Corp. (AHCO) Stock Analysis: Robust Analyst Ratings and Nearly 50% Potential Upside 17 June 2025
UFP Technologies, Inc. (UFPT) Stock Analysis: Riding a 41% Revenue Growth Wave with a 30% Upside Potential 17 June 2025
Neogen Corporation (NEOG) Stock Analysis: Uncovering a 59% Potential Upside Amid Healthcare Challenges 17 June 2025
GeneDx Holdings Corp. (WGS) Stock Analysis: Harnessing 39.6% Revenue Growth with a 42% Upside Potential 17 June 2025
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 35.55% Potential Upside with a Strong Hold Consensus 17 June 2025
Twist Bioscience Corporation (TWST): Analyst Consensus and Growth Potential Highlight a Promising Investment Opportunity 17 June 2025
Janux Therapeutics, Inc. (JANX) Stock Analysis: Biotechnology Pioneer with 256.30% Potential Upside 17 June 2025
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Powerhouse with a 132.91% Potential Upside 17 June 2025
LivaNova PLC (LIVN) Stock Analysis: Unveiling a 35.82% Upside Potential in the Medical Devices Market 17 June 2025
Viking Therapeutics, Inc. (VKTX): Analyst Ratings Highlight a Potential 234% Upside for Investors 17 June 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 108% Upside in the Biotech Sector 17 June 2025
Hercules Plc Training 2,000 Workers to Help Solve the UK Infrastructure Skills Crisis (Video) 17 November 2025
Firering Strategic Minerals $1M Ricca Settlement Injects Momentum into Lithium Strategy (Video) 14 November 2025
ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video) 11 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026